Chembio Diagnostics Inc. (NASDAQ:CEMI) went down by -16.26% from its latest closing price compared to the recent 1-year high of $8.75. The company’s stock price has collected -20.77% of loss in the last five trading sessions. Press Release reported 1 hour ago that Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil
Is It Worth Investing in Chembio Diagnostics Inc. (NASDAQ :CEMI) Right Now?
Plus, the 36-month beta value for CEMI is at 1.90. Opinions of the stock are interesting as 2 analysts out of 3 who provided ratings for Chembio Diagnostics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $6.00. CEMI currently public float of 18.55M and currently shorts hold a 7.50% ratio of that float. Today, the average trading volume of CEMI was 485.13K shares.
CEMI’s Market Performance
CEMI stocks went down by -20.77% for the week, with a monthly drop of -32.01% and a quarterly performance of -43.25%, while its annual performance rate touched -58.30%. The volatility ratio for the week stands at 7.19% while the volatility levels for the past 30 days are set at 5.34% for Chembio Diagnostics Inc.. The simple moving average for the period of the last 20 days is -26.01% for CEMI stocks with a simple moving average of -55.28% for the last 200 days.
Analysts’ Opinion of CEMI
Many brokerage firms have already submitted their reports for CEMI stocks, with Craig Hallum repeating the rating for CEMI by listing it as a “Buy.” The predicted price for CEMI in the upcoming period, according to Craig Hallum is $10 based on the research report published on December 03rd of the previous year 2020.
Colliers Securities, on the other hand, stated in their research note that they expect to see CEMI reach a price target of $7.50. The rating they have provided for CEMI stocks is “Buy” according to the report published on November 06th, 2020.
CEMI Trading at -32.12% from the 50-Day Moving Average
After a stumble in the market that brought CEMI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.46% of loss for the given period.
Volatility was left at 5.34%, however, over the last 30 days, the volatility rate increased by 7.19%, as shares sank -28.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -39.77% lower at present.
During the last 5 trading sessions, CEMI fell by -20.77%, which changed the moving average for the period of 200-days by -57.53% in comparison to the 20-day moving average, which settled at $2.74. In addition, Chembio Diagnostics Inc. saw -56.63% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CEMI
Current profitability levels for the company are sitting at:
- -67.60 for the present operating margin
- +26.47 for the gross margin
The net margin for Chembio Diagnostics Inc. stands at -78.60. The total capital return value is set at -42.71, while invested capital returns managed to touch -50.39. Equity return is now at value -80.90, with -37.00 for asset returns.
Based on Chembio Diagnostics Inc. (CEMI), the company’s capital structure generated 91.43 points at debt to equity in total, while total debt to capital is 47.76. Total debt to assets is 30.02, with long-term debt to equity ratio resting at 88.90. Finally, the long-term debt to capital ratio is 46.44.
When we switch over and look at the enterprise to sales, we see a ratio of 2.86, with the company’s debt to enterprise value settled at 0.27. The receivables turnover for the company is 9.23 and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.22.